Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1147 participants.
Also called NCT01131182
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,147 participants
- Sponsor
- Registry
-
NCT01131182
-
- Other papers using this trial's data
- The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01131182. Randomized; no masking; primary purpose treatment. Start 2010-06-13 (actual); primary completion 2010-11-04 (actual). Results posted on 2012-01-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Intervention (Drug)
- Sitagliptin phosphate
- Intervention (Drug)
- Comparator: Sulfonylurea
- Intervention (Drug)
- Metformin
- Lead sponsor
- Merck Sharp & Dohme LLC
Record details
- Record id
cardio:ct-nct01131182- Content hash
da3248494e98d1e6a8bbe1815afb43bf7a571c56b8aff4cb8cafd6620789e0e2